LYEL vs PDD · rev $6.0K vs P/E 8.4, rev $61.75B
Lyell Immunopharma Inc (LYEL) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
LYEL currently screens at market cap $143.5M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the LYEL and PDD stock pages for the full models.
Not investment advice.